LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. TI=Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia
  2. TI=Psychological Effects of Home Confinement and Social Distancing Derived from COVID 19 in the General Population A Systematic Review

Search results

Result 1 - 1 of total 1

Search options

Article: Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia.

Chen, Chun-Yu / Wang, Feng-Lin / Lin, Chih-Chuan

Clinical toxicology (Philadelphia, Pa.)

2006  Volume 44, Issue 2, Page(s) 173–175

Abstract: ... interval syndrome with a refractory ventricular arrhythmia. She was receiving chronic therapeutic doses ... after treatment with lidocaine and isoproterenol.: Conclusion: The chronic use of HCQ for rheumatic diseases ... of her ventricular tachycardia. After discontinuing the HCQ, the QT interval was shorter and the patient recovered ...

Abstract Background: Hydroxychloroquine (HCQ) is used for treatment of lupus erythematosus. The cardiac toxicity of HCQ has focused primarily on acute intoxication. We report a case of chronic use of HCQ associated with torsade de pointes.
Case report: A 67-year-old female presented with acquired long QT interval syndrome with a refractory ventricular arrhythmia. She was receiving chronic therapeutic doses of HCQ for the treatment of lupus erythematosus. Torsades de pointes was diagnosed in the Emergency Department (ED). After excluding other causes of long QT syndrome, the HCQ was suspected as the cause of her ventricular tachycardia. After discontinuing the HCQ, the QT interval was shorter and the patient recovered after treatment with lidocaine and isoproterenol.
Conclusion: The chronic use of HCQ for rheumatic diseases, or as an anti-malarial drug, should be balanced against the risk of developing potentially lethal cardiac arrhythmias.
MeSH term(s) Aged ; Antirheumatic Agents/administration & dosage ; Antirheumatic Agents/adverse effects ; Antirheumatic Agents/therapeutic use ; Electrocardiography ; Female ; Humans ; Hydroxychloroquine/administration & dosage ; Hydroxychloroquine/adverse effects ; Hydroxychloroquine/therapeutic use ; Long QT Syndrome/chemically induced ; Lupus Erythematosus, Systemic/drug therapy ; Time Factors ; Ventricular Premature Complexes/chemically induced
Chemical Substances Antirheumatic Agents ; Hydroxychloroquine (4QWG6N8QKH)
Language English
Publishing date 2006-04-12
Publishing country England
Document type Case Reports ; Journal Article
ZDB-ID 204476-6
ISSN 1556-9519 ; 1556-3650 ; 0009-9309 ; 0731-3810
ISSN (online) 1556-9519
ISSN 1556-3650 ; 0009-9309 ; 0731-3810
DOI 10.1080/15563650500514558
Shelf mark
Zs.B 419: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top